Hematogenix is a specialty reference laboratory specializing in oncology research and diagnostics. The company provides molecular diagnostic tests, histology testing, and validation services for pharmaceutical and biotech companies, diagnostic developers, and oncologists. Hematogenix offers a variety of validated IHC/ISH assays, NGS services, and biomarker development and testing services, as well as FDA-approved companion diagnostic immuno-oncology tests for triple-negative breast cancer. The company's clinical laboratories are CAP and CLIA certified, and they focus on providing accurate diagnosis and monitoring of hematological disorders, as well as monitoring measurable/minimal residual disease. Additionally, Hematogenix provides comprehensive assays by flow cytometry to assess the immune response, with a targeted focus on PD-L1 in multiple disease types.
Headquarters
A4-1 Block A, Jalan Radius 1/1B, Jalan Teknokrat 2/1 Radius Business Park,Cyber 4
Cyberjaya; Selangor;
Postal Code: 63000
Contact Details: Purchase the Hematogenix Sdn. Bhd. report to view the information.
Website: http://hematogenix.com/
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service